Cargando…
Suppression of MyD88-dependent signaling alleviates neuropathic pain induced by peripheral nerve injury in the rat
BACKGROUND: MyD88 is the adaptor protein of MyD88-dependent signaling pathway of TLRs and IL-1 receptor and regulates innate immune response. However, it was not clear whether and how MyD88 and related signaling pathways in the dorsal root ganglion (DRG) and spinal dorsal horn (SDH) are involved in...
Autores principales: | Liu, Fan, Wang, Zhiyao, Qiu, Yue, Wei, Min, Li, Chunyan, Xie, Yikuan, Shen, Le, Huang, Yuguang, Ma, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5374701/ https://www.ncbi.nlm.nih.gov/pubmed/28359290 http://dx.doi.org/10.1186/s12974-017-0822-9 |
Ejemplares similares
-
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
por: Chen, Junbin, et al.
Publicado: (2020) -
Botulinum toxin type A alleviates neuropathic pain and suppresses inflammatory cytokines release from microglia by targeting TLR2/MyD88 and SNAP23
por: Wang, Xuan, et al.
Publicado: (2020) -
Suppression of TLR4-MyD88 signaling pathway attenuated chronic mechanical pain in a rat model of endometriosis
por: Su, Wenliang, et al.
Publicado: (2021) -
MyD88 and beyond: a perspective on MyD88-targeted therapeutic approach for modulation of host immunity
por: Saikh, Kamal U.
Publicado: (2021) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
por: Luo, Wu, et al.
Publicado: (2022)